Nour Fatema Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
faculty
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Nour Fatema's research investigates the functional consequences of post-translational modifications, particularly lysine acetylation, on metabolic enzymes. Her work includes characterizing lysine acetylation of glucokinase and studying citric acid cycle enzymes using genetic code expansion. She has also examined the functional consequences of lysine acetylation on phosphofructokinase isozymes. Fatema has explored the pharmacological potentials of flavonoids and the modifications of cellulose-based biomaterials for biomedical applications. Additionally, her research has utilized immunoinformatic and molecular docking approaches for siRNA prediction to silence cell surface binding proteins of the monkeypox virus and investigated the bioactive components of Annona Reticulata for enhanced antibiotic effects. Fatema collaborates with Chenguang Fan, Qinglei Gan, Ruben Michael Ceballos, and Nazim Uddin Emon at the University of Arkansas at Fayetteville.
Metrics
- h-index: 5
- Publications: 13
- Citations: 289
Selected Publications
-
Functional consequences of lysine acetylation of phosphofructokinase isozymes (2025)
-
Characterizing lysine acetylation of glucokinase (2023)
-
In silico prediction of siRNA to silence the SARS-CoV-2 omicron variant targeting BA.4, BA.5, BQ.1, BQ1.1. and XBB: an alternative to traditional therapeutics (2023)
-
Studying lysine acetylation of citric acid cycle enzymes by genetic code expansion (2023)
-
In-Silico Prediction of Sirna to Silence the Sars-Cov-2 Omicron Variant Specifically Ba.4 and Ba.5: An Alternative to Traditional Therapeutics (2023)
-
Modifications of cellulose-based biomaterials for biomedical applications (2022)
-
Comparisons of Catalytic Efficiency during the Reduction of Lignocellulosic Substrates between Free Enzyme and Enzyme bound to Mobile Enzyme Sequestration Platforms (MESP) (2021)
Collaboration Network
Top Collaborators
- Modifications of cellulose-based biomaterials for biomedical applications
- Characterizing lysine acetylation of glucokinase
- Studying lysine acetylation of citric acid cycle enzymes by genetic code expansion
- Functional consequences of lysine acetylation of phosphofructokinase isozymes
- Author response for "Functional consequences of lysine acetylation of phosphofructokinase isozymes"
- Immunoinformatic and molecular docking approaches: siRNA prediction to silence cell surface binding protein of monkeypox virus
- In-Silico Prediction of Sirna to Silence the Sars-Cov-2 Omicron Variant Specifically Ba.4 and Ba.5: An Alternative to Traditional Therapeutics
- Natural Constituents in Annona Reticulata Potentiate the Activities of the Existing Antibiotics and Serve as a Promising Resource for the Bioactive Compounds
- In silico prediction of siRNA to silence the SARS-CoV-2 omicron variant targeting BA.4, BA.5, BQ.1, BQ1.1. and XBB: an alternative to traditional therapeutics
- Unveiling Annona Reticulata's Bioactive Arsenal for Enhanced Antibiotic Effects
- Immunoinformatic and molecular docking approaches: siRNA prediction to silence cell surface binding protein of monkeypox virus
- In-Silico Prediction of Sirna to Silence the Sars-Cov-2 Omicron Variant Specifically Ba.4 and Ba.5: An Alternative to Traditional Therapeutics
- Natural Constituents in Annona Reticulata Potentiate the Activities of the Existing Antibiotics and Serve as a Promising Resource for the Bioactive Compounds
- In silico prediction of siRNA to silence the SARS-CoV-2 omicron variant targeting BA.4, BA.5, BQ.1, BQ1.1. and XBB: an alternative to traditional therapeutics
- Unveiling Annona Reticulata's Bioactive Arsenal for Enhanced Antibiotic Effects
- Immunoinformatic and molecular docking approaches: siRNA prediction to silence cell surface binding protein of monkeypox virus
- In-Silico Prediction of Sirna to Silence the Sars-Cov-2 Omicron Variant Specifically Ba.4 and Ba.5: An Alternative to Traditional Therapeutics
- Natural Constituents in Annona Reticulata Potentiate the Activities of the Existing Antibiotics and Serve as a Promising Resource for the Bioactive Compounds
- In silico prediction of siRNA to silence the SARS-CoV-2 omicron variant targeting BA.4, BA.5, BQ.1, BQ1.1. and XBB: an alternative to traditional therapeutics
- Unveiling Annona Reticulata's Bioactive Arsenal for Enhanced Antibiotic Effects
- Characterizing lysine acetylation of glucokinase
- Functional consequences of lysine acetylation of phosphofructokinase isozymes
- Author response for "Functional consequences of lysine acetylation of phosphofructokinase isozymes"
- Characterizing lysine acetylation of glucokinase
- Functional consequences of lysine acetylation of phosphofructokinase isozymes
- Author response for "Functional consequences of lysine acetylation of phosphofructokinase isozymes"
- Modifications of cellulose-based biomaterials for biomedical applications
- Comparisons of Catalytic Efficiency during the Reduction of Lignocellulosic Substrates between Free Enzyme and Enzyme bound to Mobile Enzyme Sequestration Platforms (MESP)
- In-Silico Prediction of Sirna to Silence the Sars-Cov-2 Omicron Variant Specifically Ba.4 and Ba.5: An Alternative to Traditional Therapeutics
- In silico prediction of siRNA to silence the SARS-CoV-2 omicron variant targeting BA.4, BA.5, BQ.1, BQ1.1. and XBB: an alternative to traditional therapeutics
- In-Silico Prediction of Sirna to Silence the Sars-Cov-2 Omicron Variant Specifically Ba.4 and Ba.5: An Alternative to Traditional Therapeutics
- In silico prediction of siRNA to silence the SARS-CoV-2 omicron variant targeting BA.4, BA.5, BQ.1, BQ1.1. and XBB: an alternative to traditional therapeutics
- In-Silico Prediction of Sirna to Silence the Sars-Cov-2 Omicron Variant Specifically Ba.4 and Ba.5: An Alternative to Traditional Therapeutics
- In silico prediction of siRNA to silence the SARS-CoV-2 omicron variant targeting BA.4, BA.5, BQ.1, BQ1.1. and XBB: an alternative to traditional therapeutics
- Natural Constituents in Annona Reticulata Potentiate the Activities of the Existing Antibiotics and Serve as a Promising Resource for the Bioactive Compounds
- Unveiling Annona Reticulata's Bioactive Arsenal for Enhanced Antibiotic Effects
- Natural Constituents in Annona Reticulata Potentiate the Activities of the Existing Antibiotics and Serve as a Promising Resource for the Bioactive Compounds
- Unveiling Annona Reticulata's Bioactive Arsenal for Enhanced Antibiotic Effects
- Natural Constituents in Annona Reticulata Potentiate the Activities of the Existing Antibiotics and Serve as a Promising Resource for the Bioactive Compounds
- Unveiling Annona Reticulata's Bioactive Arsenal for Enhanced Antibiotic Effects
- Natural Constituents in Annona Reticulata Potentiate the Activities of the Existing Antibiotics and Serve as a Promising Resource for the Bioactive Compounds
- Unveiling Annona Reticulata's Bioactive Arsenal for Enhanced Antibiotic Effects
- Natural Constituents in Annona Reticulata Potentiate the Activities of the Existing Antibiotics and Serve as a Promising Resource for the Bioactive Compounds
- Unveiling Annona Reticulata's Bioactive Arsenal for Enhanced Antibiotic Effects
Similar Researchers
Based on overlapping research topics